| Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416) |
|---|
| 05/18/2005 | CN1616436A 4-alkoxy cyclohexane-1 amino carboxylic acid esters and method for the production thereof |
| 05/18/2005 | CN1616417A Photo-stable cosmetic and pharmaceutical formulations containing UV-filters |
| 05/18/2005 | CN1616415A Continuous ion exchage extracting process for L-phenylalanine |
| 05/18/2005 | CN1616414A DL-beta-amino butyric acid derivative and its preparing method and use |
| 05/18/2005 | CN1616413A Method for preparing glycine |
| 05/18/2005 | CN1202076C Production method of N-benzyl glycine ethyl ester |
| 05/18/2005 | CN1202075C One-pot synthesis of alkyl 3-cyclopropylamino-2-[2,4-dibromo-3-(difruoromethoxy) benzoyl]-2-propenoate as useful intermediate for antibacterial quinolone medicaments |
| 05/12/2005 | WO2005042481A2 COMPOUNDS AND RELATED METHODS FOR MUTANT p53 REACTIVATION |
| 05/12/2005 | WO2005042469A1 Aromatic amino acid labeled with stable isotope, method for incorporating the same into target protein and method for analyzing protein structure using nmr |
| 05/12/2005 | WO2005042468A1 Method for producing 2-dihaloacyl-3-amino-acrylic acid esters and 3-dihalomethyl-pyrazole-4-carboxylic acid esters |
| 05/12/2005 | WO2005041928A1 Compositions and dosage forms for ehnanced absorption of iron |
| 05/12/2005 | WO2005041927A1 Compositions and dosage forms for enhanced absorption of gabapentin and pregabalin |
| 05/12/2005 | WO2005041926A1 Compositions and dosage forms for enhanced absorption of 3-amino-n-butyl-phosphinic acid |
| 05/12/2005 | WO2005041925A2 Compositions and dosage forms for enhanced absorption |
| 05/12/2005 | WO2005041924A2 Administration of levodopa and carbidopa |
| 05/12/2005 | WO2005041923A1 Compositions and dosage forms for enhanced absorption of metformin |
| 05/12/2005 | US20050101744 T-butyl cascade polymers |
| 05/12/2005 | US20050101671 Compounds and compositions for delivering active agents |
| 05/12/2005 | US20050101661 Cyclooxygenase inhibitors; musculoskeletal and cardiovascular disorders; antiinflammatory agents |
| 05/12/2005 | US20050101643 Amino acids with affinity for the alpha2delta-protein |
| 05/12/2005 | US20050101572 Improved lipophilicity, toxicity, bioavailability, and pharmacokinetics; for treatment of cardiovascular and neurological disorders |
| 05/12/2005 | US20050100993 omega-carboxy-2-hydroxy- ethyl- or propyl-amines, 1-substituted with thienyl, phenyl, pyridyl, allyl or propargyl; used in synthesis of pharmaceuticals |
| 05/12/2005 | CA2543945A1 Compositions and dosage forms for enhanced absorption of 3-amino-n-butyl-phosphinic acid |
| 05/12/2005 | CA2543238A1 Compositions and dosage forms for enhanced absorption |
| 05/12/2005 | CA2543227A1 Administration of levodopa and carbidopa |
| 05/12/2005 | CA2543185A1 Compositions and dosage forms for ehnanced absorption of iron |
| 05/12/2005 | CA2543181A1 Compositions and dosage forms for enhanced absorption of gabapentin and pregabalin |
| 05/12/2005 | CA2543177A1 Compositions and dosage forms for enhanced absorption of metformin |
| 05/11/2005 | EP1529775A1 Method for preparation of metal organic acid chelates |
| 05/11/2005 | EP1529774A2 Process for the preparation of an organozinc derivative and its use in a zinc-containing composition as nutritional supplement |
| 05/11/2005 | EP1529037A2 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof |
| 05/11/2005 | EP1529030A2 Derivatives of glycinergic r(+)-2-amino-3-hydroxypropanoic acid |
| 05/11/2005 | EP1529029A1 Method for producing 3-amino-4,4,4-trifluorocrotonic acid esters |
| 05/11/2005 | EP1286590A4 Peptide analogs and mimetics suitable for in vivo use in the treatment of diseases associated with abnormal protein folding into amyloid, amyloid-like deposits or beta-sheet rich pathological precursor thereof |
| 05/11/2005 | EP1069107B1 Fullerene derivatives |
| 05/11/2005 | EP1033362B1 Crystals of [s,s]-ethylenediamine-n,n'-disuccinic acid with high bulk density and method of obtaining the same |
| 05/11/2005 | CN1615312A Synthetic hydrotalcites, syntheses and uses |
| 05/10/2005 | US6891066 For therapy of cancer, restenosis, psoriasis, autoimmune disease, atherosclerosis, osteoarthritis, rheumatoid arthritis, heart failure, chronic pain, and neuropathic pain |
| 05/10/2005 | US6891059 Asymmetric catalytic hydrogenation of specified alkene in presence of solvent and chiral catalyst comprising chiral phosphine ligand to prepare (S)-3-cyano-5-methylhexanoic acid derivative |
| 05/10/2005 | CA2303801C Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists |
| 05/10/2005 | CA2097044C Cyclopentane- and -pentene-.beta.-amino acids |
| 05/06/2005 | WO2004002939A3 Aminoalcohol derivatives |
| 05/05/2005 | US20050095652 Solid support comprising immobilized biopolymers for use as assay in monitoring receptor ligand interaction; drug screening; antibodiy sensitivity |
| 05/04/2005 | EP1528076A1 Methods of synthesis of polysuccinimide, copolymers of polysuccinimide and derivatives thereof |
| 05/04/2005 | EP1528075A1 Methods of synthesis of polysuccinimide copolymers of polysuccinimide and derivatives thereof |
| 05/04/2005 | EP1526917A2 Novel nickel-carbene, palladium-carbene and platinum-carbene complexes, their production and use in catalytic reactions |
| 05/04/2005 | EP1246790B1 Substituted 1 and 2 naphthol mannich bases |
| 05/04/2005 | CN1612887A Phosphino-aminophosphines |
| 05/04/2005 | CN1612871A Processes and intermediates for preparing benzyl epoxides |
| 05/04/2005 | CN1612852A Lipoxin A4 analogs |
| 05/04/2005 | CN1612729A 2-aryl-propionic acid and medicine composition containing same |
| 05/04/2005 | CN1611487A Novel method for extracting 4-hydroxy isoleucine product from trigonella |
| 05/03/2005 | US6888029 Arylation complex catalyst |
| 05/03/2005 | US6887971 Such as liquid carbon dioxide starting with an aminoacid such as L-aspartic acid |
| 05/03/2005 | CA2190570C Process for producing 3-amino-2-oxo-1-halogenopropane derivatives |
| 04/30/2005 | CA2447584A1 Preparation of metal organic acid chelates |
| 04/28/2005 | WO2005037882A1 Polymers based on n,n-diallylamine derivatives, their production and use |
| 04/28/2005 | WO2005037793A1 Cyclopentene compounds |
| 04/28/2005 | WO2005037784A2 Crystalline form of gamma-aminobutyric acid analog |
| 04/28/2005 | WO2005037779A2 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | WO2005037737A1 Method for the production of [18f] fluoride-marked aromatic l-amino acids |
| 04/28/2005 | US20050090687 Oxidizing primary amino alcohol in presences of dichromate and/or chromium oxide catalyst to form acid/ketone |
| 04/28/2005 | US20050090669 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| 04/28/2005 | US20050090539 Intermediates for making 1(alpha-amino-1-(cyclopropyl-fused pyrrolidinylcarbonyl)methyl)-3-hydroxyadamantanes, e.g., methyl 3-hydroxy-<a-oxotricyclo[3.3.1.13,7]decane-1-acetate |
| 04/28/2005 | CA2542807A1 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | CA2539157A1 Polymers based on n,n-diallylamine derivatives, their production and use |
| 04/27/2005 | EP1526127A2 Process for production of S,S-ethylenediamine-N,N'-disuccinic acid iron alkali salt |
| 04/27/2005 | EP1525186A1 Inhibitors of hcv ns5b polymerase |
| 04/27/2005 | EP1525183A1 Inhibitors of hcv ns5b polymerase |
| 04/27/2005 | EP1525182A1 Photoactive materials |
| 04/27/2005 | EP1525181A1 Process for the preparation of phenylalanine enamide derivatives |
| 04/27/2005 | EP1357910B1 Method for preventing and treating visceral pain and gastrointestinal disorders |
| 04/27/2005 | EP1144360B1 A method for the synthesis of compounds of formula 1 and derivatives thereof |
| 04/27/2005 | CN1610658A Processes for the preparation of glutamic acid compounds and intermediates thereof and novel intermediates used in the processes |
| 04/27/2005 | CN1610657A Process for the preparation of intermediates useful in the synthesis of statin derivatives especially 7-amino 3, 5-dihydroxy heptanoic acid derivatives, and intermediates thereof |
| 04/27/2005 | CN1610557A 6-fluorobicyclo 3.1.0 hexane derivatives |
| 04/27/2005 | CN1610544A Method for preventing and treating visceral pain and gastrointestinal disorders |
| 04/27/2005 | CN1609097A Serine synthesizing process |
| 04/27/2005 | CN1609095A Solid phase synthesis process of amino acid chelate adopting airflow synergizing microwave technology |
| 04/27/2005 | CN1198794C Stable lysine solution |
| 04/26/2005 | US6884903 Substituted sulfonylaminomethylbenzoic acid (derivatives) and their preparation |
| 04/26/2005 | US6884887 Method for producing amines by homogeneously catalyzed reductive amination of carbonyl compounds |
| 04/26/2005 | CA2194203C Process for the preparation of o-chloromethyl-phenylglyoxylic acid derivatives |
| 04/21/2005 | WO2005035482A2 Process for preparing aspartates |
| 04/21/2005 | WO2005021485A3 Cycloalkylaminoacid compounds, processes for making and uses thereof |
| 04/21/2005 | WO2005020882A3 Compound capable of binding s1p receptor and pharmaceutical use thereof |
| 04/21/2005 | US20050085545 Alkylation a cyanoester compound with dibromopropane; cyclization; amination |
| 04/21/2005 | US20050085544 Alkylation a cyanoester with dibromopropane; cyclization |
| 04/21/2005 | US20050084452 Deuterated hydrogen in protein, radioactive carbon or nitrogen; bioassay of accurate analyzing the structure of the target high molecular weight protein; producing stable isotope-labeled fumaric acid, tartaric acid through esterification, oxidation, hydrolysis; chemical peptide synthesis |
| 04/20/2005 | EP1365737B1 Stable salts of o-acetylsalicyclic with basic amino acids |
| 04/20/2005 | EP1320534B1 Combretastatin a-4 phosphate prodrug salts with nitrogen-containing compounds |
| 04/20/2005 | EP1226110B1 Bicyclic amino acids as pharmaceutical agents |
| 04/20/2005 | EP1165495B1 Resorcinol derivatives |
| 04/20/2005 | CN1607201A Method for the stereoselective synthesis of cyclic amino acids |
| 04/20/2005 | CN1197839C Stibene derivative organic amine salt, its preparation method, use and medicinal composition |
| 04/19/2005 | US6881861 Transformation of 2-aminoglutaric acid crystal structures, by maintaining the crystals in solvent as slurries in the presence of activated carbon |
| 04/14/2005 | WO2005033128A1 Method for the synthesis of n-[(s)-1-carbethoxybutyl]-(s)-alanine and use thereof for the synthesis of perindopril |
| 04/14/2005 | WO2005033127A1 Method for the synthesis of n-[(s)-1-carbethoxybutyl]-(s)-alanine and use thereof for the synthesis of perindopril |
| 04/14/2005 | WO2005033056A2 Triphenylethylene compounds as selective estrogen receptor modulators |
| 04/14/2005 | WO2005009928A3 Preparation and use of alkylating agents |